Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
about
The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infectionTwo highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytesCurrent understanding of the mechanism of HPV infectionThe viral etiology of AIDS-associated malignanciesBinding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection.Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression.Mechanisms of cell entry by human papillomaviruses: an overview.The role of furin in papillomavirus infection.Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection.Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections.Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of L2, the minor capsid protein.Assembly and translocation of papillomavirus capsid proteins.Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1Minor capsid proteins of simian virus 40 are dispensable for nucleocapsid assembly and cell entry but are required for nuclear entry of the viral genome.Papillomavirus capsid proteins mutually impact structureCell surface-binding motifs of L2 that facilitate papillomavirus infection.Interactions between papillomavirus L1 and L2 capsid proteinsImmunoprevention of human papillomavirus-associated malignanciesChimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16The HPV16 and MusPV1 papillomaviruses initially interact with distinct host components on the basement membraneEmerging therapies for human papillomavirus infection.Immunotherapy for gynaecological malignancies.Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection.Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection.The evolving field of human papillomavirus receptor research: a review of binding and entry.L2, the minor capsid protein of papillomavirus.Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus.A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding.Principles of polyoma- and papillomavirus uncoating.Coat as a dagger: the use of capsid proteins to perforate membranes during non-enveloped DNA viruses trafficking.Papillomavirus assembly: An overview and perspectives.Developments in L2-based human papillomavirus (HPV) vaccines.Further evidence that papillomavirus capsids exist in two distinct conformations.The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.
P2860
Q21134079-62E39AC7-6C9B-4CC5-95CD-FECEE2D68E49Q21143868-600DA309-9CCD-48F2-8314-A5414DA801D2Q24616134-5CAA2512-4D9A-4181-8F58-A078A68ABACCQ24685892-92F7110E-DBDD-4116-AD1A-AFE70F10978AQ27472837-280A38AF-6A9B-47AF-AEF4-318FCCCB4338Q30764287-FF0D7F29-C209-4D71-BCBE-3E1C48E226B3Q33604135-EA05689A-B578-48C7-8961-9E04098AB1D2Q33663169-7F0E03E7-3F95-4644-8D01-3484E6FFA766Q33693739-AFD5E405-A0D3-4216-9430-02D925320B32Q33848323-C8FBEF35-D802-40C8-843B-AFA2D7C466C3Q34162277-56684638-A51A-4992-8764-877D78CB14A8Q34347179-AEA9A0C9-CE2F-4ABE-ADC8-6C236804B73AQ34347720-0B552759-AF50-4069-AC15-B064E355225BQ34408919-68588E55-2057-4C27-8833-F5981321EA7BQ34434903-1BC4259A-0640-489A-822A-0324E75F3110Q34608139-368E35DC-E118-4732-9E78-137F342D6C1FQ34699403-2338F96D-E92A-4CDF-AE14-226DC9A32FFBQ34743921-021A4CC4-FB21-421C-BC02-CEB31AB18951Q34860943-313DE474-E920-4C70-A2FD-5904C73E435AQ35044376-8C980EAF-3CB9-4741-9E73-5024CEE39334Q35155333-11E96047-4244-445F-AB10-B9418228C060Q35624920-40B57A47-5FF7-407A-893E-BAE1CDD65D1FQ36179672-84922B7A-6AED-40CC-8F0A-2A94FB79A30FQ36239661-3C4CE24D-AC8E-4F68-8464-93208EB6A2F3Q36240497-4CBFCAD7-8CCF-4CE6-B384-51E21FFFA4A4Q36314993-A9C51571-7134-4185-B648-41F577D6D632Q36333638-3FA04D6F-F757-4BAD-8C92-6A2E12202AC0Q36545925-43DDB56A-EB42-4E65-9D7A-76EC0040D9B1Q36720700-4CA50F84-84E0-4D40-82AC-36DD329B423BQ36827213-847B0351-5600-49F7-B038-A3206D72FBDDQ37164879-606A6F59-CA2E-4490-9462-39E84039FD6BQ37480444-D1486878-D7CC-402B-89B2-174B24F4D54CQ37604412-BB4C18A1-ECA1-4FC1-B5C5-3C4169563848Q37683446-57331526-587C-43F3-9790-483BEC3BDB3FQ38045782-6091C11A-C8F0-4E0B-A9E0-925A3EDDBE0AQ38233232-8EAC0F67-CD0D-4CE3-96C6-F631CC6ACD90Q38795804-45D3E115-BEF1-4A73-BA26-A00D9C41E15AQ39021001-55E98DD9-5FD8-4D77-9284-0D11D0B5A894Q40344553-15641574-8E74-432F-BD08-16D10B306A04Q40446848-5CA89874-6F72-43B0-B6AD-AA4AED0F0BBE
P2860
Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Human papillomavirus type 16 m ...... face and enters the cytoplasm.
@ast
Human papillomavirus type 16 m ...... face and enters the cytoplasm.
@en
type
label
Human papillomavirus type 16 m ...... face and enters the cytoplasm.
@ast
Human papillomavirus type 16 m ...... face and enters the cytoplasm.
@en
prefLabel
Human papillomavirus type 16 m ...... face and enters the cytoplasm.
@ast
Human papillomavirus type 16 m ...... face and enters the cytoplasm.
@en
P2093
P2860
P1433
P1476
Human papillomavirus type 16 m ...... face and enters the cytoplasm.
@en
P2093
P2860
P304
P356
10.1128/JVI.75.5.2331-2336.2001
P577
2001-03-01T00:00:00Z